• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cellceutix Corp

+ Add to Watchlist


2.500 EUR 0.0000.00%

As of 09:45:24 ET on 11/28/2014.

Snapshot for Cellceutix Corp (C0C)

Open: - Day's Range: - Volume: 0
Previous Close: 2.500 52wk Range: 1.027 - 3.200 1-Yr Rtn: -

Stock Chart for C0C

No chart data available.
  • C0C:GR 2.500
  • 1D
  • 1M
  • 1Y
Interactive C0C Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for C0C

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 285.59
Shares Outstanding (M) 114.24
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for C0C

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for C0C

Cellceutix Corporation is a development-stage biopharmaceutical company. The Company's current portfolio of product candidates in pre-clinical development includes anti-cancer agents targeting multiple tumors, candidate targeting rheumatoid arthritis, candidate with potential for indications of osteo-arthritis/asthma, candidate being developed for autism.

Leo EhrlichChairman/CEO/CFOKrishna MenonPres/Chief Scientific Ofcr/Founder
William James AlexanderChief Operations Officer
More Company Profile & Key Executives for C0C

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil